Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review

Overview of attention for article published in Anticancer Research: International Journal of Cancer Research and Treatment, January 2017